Deprenyl is metabolized to methamphetamine and amphetamine in man.

This publication has 15 references indexed in Scilit:

• Anti-depressant potentiation of 5-hydroxytryptophan by L-deprenyl, an MAO ?type B? inhibitor
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1978
• Evidence that deprenyl, a type B monoamine oxidase inhibitor, is an indirectly acting sympathomimetic amine
  Biochemical Pharmacology, 1978
• IMPLICATIONS OF COMBINED TREATMENT WITH 'MADOPAR' AND L-DEPRENIL IN PARKINSON'S DISEASE
  The Lancet, 1977
• Dopamine is a monoamine oxidase B substrate in man
  Nature, 1977
• Identification and distribution of benzylamine in tissue extracts isolated from rats pretreated with pargyline
  Biochemical Pharmacology, 1976
• The Metabolism of Amphetamines in Mammals
  Drug Metabolism Reviews, 1976
• Amphetamines in the treatment of Parkinson's disease.
  Journal of Neurology, Neurosurgery & Psychiatry, 1975
• Phenethylamines in brain and liver of rats with experimentally induced phenylketonuria-like characteristics
  Biochemical Journal, 1973
• Urinary Excretion of Methylamphetamine in Man
  Nature, 1965
• Biochemical Theories of Schizophrenia
  Science, 1959